Skip to content

An Exploratory Study of Atherosclerosis/Bleeding Risk Events in Patients Undergoing Percutaneous Coronary Intervention

An Exploratory Study of Atherosclerosis/Bleeding Risk Events in Patients Undergoing Percutaneous Coronary Intervention - Exploratory Study on Post-PCI Atherosclerosis/Bleeding Risk and Events

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049264
Enrollment
800
Registered
2022-10-19
Start date
2022-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease

Interventions

None listed

Sponsors

Nihon University School of Medicine Department of Cardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing PCI

Exclusion criteria

Exclusion criteria: If you refuse to participate in the research

Design outcomes

Primary

MeasureTime frame
Cardiovascular bleeding composite endpoint (total death + nonfatal myocardial infarction + angina requiring revascularization + stent thrombosis + stroke + major bleeding event (BARC 3 or 5))

Countries

Japan

Contacts

Public ContactKEISUKE KOJIMA

Nihon University Itabashi Hospital Department of Cardiology

kojima.keisuke@nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026